Benitec Acquires Avocel, Turns it into US Subsidiary | GenomeWeb

NEW YORK, May 17 (GenomeWeb News) - RNAi therapeutics company Benitec has acquired startup Avocel and will make it its US subsidiary, the Queensland, Australia-based company said today.

 

Under the agreement, Benitec will issue 7.6 million shares to Avocel, representing approximately 9 percent of its enlarged share capital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.